223 related articles for article (PubMed ID: 17163188)
21. Neutral-red reaction is related to virulence and cell wall methyl-branched lipids in Mycobacterium tuberculosis.
Cardona PJ; Soto CY; Martín C; Giquel B; Agustí G; Andreu N; Guirado E; Sirakova T; Kolattukudy P; Julián E; Luquin M
Microbes Infect; 2006 Jan; 8(1):183-90. PubMed ID: 16182591
[TBL] [Abstract][Full Text] [Related]
22. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
23. [Role of bacterial constituents in the virulence of tubercle bacilli].
Kato M
Kekkaku; 1967 Aug; 42(8):303-7. PubMed ID: 4966676
[No Abstract] [Full Text] [Related]
24. Pathogenicity in the tubercle bacillus: molecular and evolutionary determinants.
Gordon SV; Bottai D; Simeone R; Stinear TP; Brosch R
Bioessays; 2009 Apr; 31(4):378-88. PubMed ID: 19274661
[TBL] [Abstract][Full Text] [Related]
25. Tubercle bacilli generate a novel cell wall-associated pigment after long-term anaerobic culture.
Cunningham AF; Ashton PR; Spreadbury CL; Lammas DA; Craddock R; Wharton CW; Wheeler PR
FEMS Microbiol Lett; 2004 Jun; 235(1):191-8. PubMed ID: 15158281
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57/BL6 mice.
Qie YQ; Wang JL; Zhu BD; Xu Y; Wang QZ; Chen JZ; Wang HH
Scand J Immunol; 2008 Feb; 67(2):133-9. PubMed ID: 18201368
[TBL] [Abstract][Full Text] [Related]
27. Tuberculosis vaccine candidates based on mycobacterial cell envelope components.
Sarmiento ME; Alvarez N; Chin KL; Bigi F; Tirado Y; García MA; Anis FZ; Norazmi MN; Acosta A
Tuberculosis (Edinb); 2019 Mar; 115():26-41. PubMed ID: 30948174
[TBL] [Abstract][Full Text] [Related]
28. Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection.
Ryan AA; Nambiar JK; Wozniak TM; Roediger B; Shklovskaya E; Britton WJ; Fazekas de St Groth B; Triccas JA
J Immunol; 2009 Jun; 182(11):7172-7. PubMed ID: 19454714
[TBL] [Abstract][Full Text] [Related]
29. [Virulence factors of Mycobacterium tuberculosis].
Maulén NP
Rev Med Chil; 2011 Dec; 139(12):1605-10. PubMed ID: 22446709
[TBL] [Abstract][Full Text] [Related]
30. The PGRS domain of Mycobacterium tuberculosis PE_PGRS Rv1759c antigen is an efficient subunit vaccine to prevent reactivation in a murine model of chronic tuberculosis.
Campuzano J; Aguilar D; Arriaga K; León JC; Salas-Rangel LP; González-y-Merchand J; Hernández-Pando R; Espitia C
Vaccine; 2007 May; 25(18):3722-9. PubMed ID: 17399860
[TBL] [Abstract][Full Text] [Related]
31. Construction, molecular modeling, and simulation of Mycobacterium tuberculosis cell walls.
Hong X; Hopfinger AJ
Biomacromolecules; 2004; 5(3):1052-65. PubMed ID: 15132700
[TBL] [Abstract][Full Text] [Related]
32. [The pathogenicity factors of Mycobacterium tuberculosis].
Lazovskaia AL; Pinchuk LM
Probl Tuberk; 1988; (8):72-6. PubMed ID: 3143998
[No Abstract] [Full Text] [Related]
33. Should a new tuberculosis vaccine be administered intranasally?
Källenius G; Pawlowski A; Brandtzaeg P; Svenson S
Tuberculosis (Edinb); 2007 Jul; 87(4):257-66. PubMed ID: 17321797
[TBL] [Abstract][Full Text] [Related]
34. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
Gao H; Li K; Yu S; Xiong S
Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
[TBL] [Abstract][Full Text] [Related]
35. Tubercle bacilli rely on a type VII army for pathogenicity.
Stoop EJ; Bitter W; van der Sar AM
Trends Microbiol; 2012 Oct; 20(10):477-84. PubMed ID: 22858229
[TBL] [Abstract][Full Text] [Related]
36. Another brick in the wall.
Tonge PJ
Nat Struct Biol; 2000 Feb; 7(2):94-6. PubMed ID: 10655605
[TBL] [Abstract][Full Text] [Related]
37. Effects of membrane lipid composition on Mycobacterium tuberculosis EsxA membrane insertion: A dual play of fluidity and charge.
Ray S; Vazquez Reyes S; Xiao C; Sun J
Tuberculosis (Edinb); 2019 Sep; 118():101854. PubMed ID: 31430698
[TBL] [Abstract][Full Text] [Related]
38. Molecular modeling and simulation of Mycobacterium tuberculosis cell wall permeability.
Hong X; Hopfinger AJ
Biomacromolecules; 2004; 5(3):1066-77. PubMed ID: 15132701
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c).
Romano M; Rindi L; Korf H; Bonanni D; Adnet PY; Jurion F; Garzelli C; Huygen K
Vaccine; 2008 Nov; 26(48):6053-63. PubMed ID: 18822333
[TBL] [Abstract][Full Text] [Related]
40. Shared characteristics between Mycobacterium tuberculosis and fungi contribute to virulence.
Willcocks S; Wren BW
Future Microbiol; 2014; 9(5):657-68. PubMed ID: 24957092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
